Источники

1. Клинические рекомендации «Хроническая сердечная недостаточность» (РКО, Минздрав РФ).

2. 2023 ESC Focused Update of the 2021 ESC Guidelines for Heart Failure. Eur Heart J. 2023.

3. Mebazaa A. et al. Safety and efficacy of rapid up-titration of HF therapies (STRONG-HF). The Lancet. 2022.

4. McMurray J.J.V. et al. Angiotensin-Neprilysin Inhibition vs Enalapril (PARADIGM-HF). N Engl J Med. 2014.

5. DAPA-HF & EMPEROR-Reduced trials (iSGLT2 in HFrEF). N Engl J Med. 2019/2020.